Other side effects in this cohort included lethargy, inappetence, myelosuppression (anaemia, neutropenia and thrombocytopenia), epistaxis, dermatological disease, polyuria and polydipsia, increased liver enzymes (including alkaline phosphatase (ALP) and alanine transaminase (ALT)), azotaemia and weight loss (see Table 3). Here, GPT is linked to anemia (phenotype).